Showing 61 to 72 of 116 results
CVS Drops Eli Lilly's Zepbound from Preferred Formulary
CVS Health will remove Eli Lilly's weight-loss drug Zepbound from its preferred formulary starting July 1, 2025, prioritizing Novo Nordisk's Wegovy; this impacts 90 million CVS Caremark members and highlights the power of PBMs in shaping drug access and affordability.
CVS Drops Eli Lilly's Zepbound from Preferred Formulary
CVS Health will remove Eli Lilly's weight-loss drug Zepbound from its preferred formulary starting July 1, 2025, prioritizing Novo Nordisk's Wegovy; this impacts 90 million CVS Caremark members and highlights the power of PBMs in shaping drug access and affordability.
Progress
36% Bias Score
Sea Moss: Social Media Hype vs. Scientific Evidence
Sea moss, a red seaweed consumed for 14,000 years, has become a social media sensation, touted for skin, weight loss, and gut health benefits; however, scientific evidence supporting these claims is limited, with high iodine content posing a potential risk.
Sea Moss: Social Media Hype vs. Scientific Evidence
Sea moss, a red seaweed consumed for 14,000 years, has become a social media sensation, touted for skin, weight loss, and gut health benefits; however, scientific evidence supporting these claims is limited, with high iodine content posing a potential risk.
Progress
20% Bias Score
Sirona Weight-Loss Pill Shows Promising Results in NHS Trial
A new weight-loss pill, Sirona, currently in NHS trials, shows obese patients losing an average of 3.6kg (7.9 lbs), or roughly 10%, of their body weight in 12 weeks with no reported side effects, unlike other treatments like Ozempic and Xenical.
Sirona Weight-Loss Pill Shows Promising Results in NHS Trial
A new weight-loss pill, Sirona, currently in NHS trials, shows obese patients losing an average of 3.6kg (7.9 lbs), or roughly 10%, of their body weight in 12 weeks with no reported side effects, unlike other treatments like Ozempic and Xenical.
Progress
52% Bias Score
Semaglutide Linked to Reduced Dementia Risk in Major Studies
Two large-scale studies suggest that the weight-loss drug semaglutide, found in Wegovy and Ozempic, may significantly lower the risk of developing dementia, offering a potential preventative measure against a condition costing the UK £42 billion annually.
Semaglutide Linked to Reduced Dementia Risk in Major Studies
Two large-scale studies suggest that the weight-loss drug semaglutide, found in Wegovy and Ozempic, may significantly lower the risk of developing dementia, offering a potential preventative measure against a condition costing the UK £42 billion annually.
Progress
32% Bias Score
Body's Fat-Burning Process: How Exercise, Diet, and Genetics Influence Weight Loss
This article explains how the body uses energy and burns fat, emphasizing that both high-intensity and moderate-intensity workouts contribute to weight loss, while also highlighting the importance of post-workout nutrition and the influence of genetics and age on metabolic rate.
Body's Fat-Burning Process: How Exercise, Diet, and Genetics Influence Weight Loss
This article explains how the body uses energy and burns fat, emphasizing that both high-intensity and moderate-intensity workouts contribute to weight loss, while also highlighting the importance of post-workout nutrition and the influence of genetics and age on metabolic rate.
Progress
24% Bias Score
Artificial Sweetener Sucralose Linked to Increased Hunger and Food Cravings
A University of Southern California study found that the artificial sweetener sucralose increased hunger in participants, particularly obese individuals, by triggering a mismatch between expected and received calories, potentially exacerbating food cravings and contributing to obesity.
Artificial Sweetener Sucralose Linked to Increased Hunger and Food Cravings
A University of Southern California study found that the artificial sweetener sucralose increased hunger in participants, particularly obese individuals, by triggering a mismatch between expected and received calories, potentially exacerbating food cravings and contributing to obesity.
Progress
52% Bias Score
HIMS Stock Surges 23% on Wegovy Partnership
Hims & Hers Health (HIMS) stock surged 23% on April 29th after Novo Nordisk announced it would offer its weight-loss drug Wegovy through HIMS's platform, significantly boosting HIMS's revenue potential due to its large subscriber base and the high price of Wegovy.
HIMS Stock Surges 23% on Wegovy Partnership
Hims & Hers Health (HIMS) stock surged 23% on April 29th after Novo Nordisk announced it would offer its weight-loss drug Wegovy through HIMS's platform, significantly boosting HIMS's revenue potential due to its large subscriber base and the high price of Wegovy.
Progress
48% Bias Score
Mediterranean Diet and Exercise Prevent Bone Loss in Postmenopausal Women
A study of 924 postmenopausal women with metabolic syndrome found that those following a 30% calorie-reduced Mediterranean diet combined with regular exercise increased bone mineral density in their lower spine over three years, unlike a control group.
Mediterranean Diet and Exercise Prevent Bone Loss in Postmenopausal Women
A study of 924 postmenopausal women with metabolic syndrome found that those following a 30% calorie-reduced Mediterranean diet combined with regular exercise increased bone mineral density in their lower spine over three years, unlike a control group.
Progress
4% Bias Score
Severe Obesity Linked to Increased Risk of 16 Diseases
A Johns Hopkins University study of 270,657 people reveals that severe obesity drastically increases the risk of 16 common diseases, including sleep apnea, type 2 diabetes, and fatty liver disease, with risks increasing proportionally to BMI.
Severe Obesity Linked to Increased Risk of 16 Diseases
A Johns Hopkins University study of 270,657 people reveals that severe obesity drastically increases the risk of 16 common diseases, including sleep apnea, type 2 diabetes, and fatty liver disease, with risks increasing proportionally to BMI.
Progress
52% Bias Score
Post-Eid Weight Gain Concerns in Pakistan: Factors Affecting Weight Loss
Following Eid celebrations in Pakistan, many people are concerned about weight gain from overeating. Weight loss depends on energy expenditure (exercise intensity and duration), body's use of glycogen vs. fat, and post-workout nutrition; muscle building increases metabolism.
Post-Eid Weight Gain Concerns in Pakistan: Factors Affecting Weight Loss
Following Eid celebrations in Pakistan, many people are concerned about weight gain from overeating. Weight loss depends on energy expenditure (exercise intensity and duration), body's use of glycogen vs. fat, and post-workout nutrition; muscle building increases metabolism.
Progress
32% Bias Score
Reduced Food Pleasure Linked to Lower Neurotensin Levels in Obesity
Research reveals obese individuals experience less pleasure from food due to decreased neurotensin levels, impacting the brain's dopamine reward system; restoring neurotensin through dietary changes or genetic manipulation may offer a new approach to managing obesity.
Reduced Food Pleasure Linked to Lower Neurotensin Levels in Obesity
Research reveals obese individuals experience less pleasure from food due to decreased neurotensin levels, impacting the brain's dopamine reward system; restoring neurotensin through dietary changes or genetic manipulation may offer a new approach to managing obesity.
Progress
36% Bias Score
China Launches Nationwide Weight Management Clinics to Combat Obesity Crisis
China is launching a nationwide campaign to combat obesity, establishing weight management clinics integrating Western and Traditional Chinese Medicine, aiming to address the growing health crisis affecting over half of its adult population and projected to impact 70.5 percent by 2030.
China Launches Nationwide Weight Management Clinics to Combat Obesity Crisis
China is launching a nationwide campaign to combat obesity, establishing weight management clinics integrating Western and Traditional Chinese Medicine, aiming to address the growing health crisis affecting over half of its adult population and projected to impact 70.5 percent by 2030.
Progress
24% Bias Score
Showing 61 to 72 of 116 results